174 related articles for article (PubMed ID: 22790854)
1. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors.
Bielle F; Fréneaux P; Jeanne-Pasquier C; Maran-Gonzalez A; Rousseau A; Lamant L; Paris R; Pierron G; Nicolas AV; Sastre-Garau X; Delattre O; Bourdeaut F; Peuchmaur M
Am J Surg Pathol; 2012 Aug; 36(8):1141-9. PubMed ID: 22790854
[TBL] [Abstract][Full Text] [Related]
2. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.
Hung YP; Lee JP; Bellizzi AM; Hornick JL
Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941
[TBL] [Abstract][Full Text] [Related]
3. A study of gata3 and phox2b expression in tumors of the autonomic nervous system.
Nonaka D; Wang BY; Edmondson D; Beckett E; Sun CC
Am J Surg Pathol; 2013 Aug; 37(8):1236-41. PubMed ID: 23715162
[TBL] [Abstract][Full Text] [Related]
4. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
[TBL] [Abstract][Full Text] [Related]
6. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.
Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR
Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857
[TBL] [Abstract][Full Text] [Related]
8. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
9. PHOX2B as a Reliable Marker for Neuroblastoma in Tissue and Cytology Specimens.
Ma Y; Feng J; Zhao J; Ding D; Tian F; Chen L; Zheng J; Xiao X
J Neuropathol Exp Neurol; 2021 Dec; 80(12):1108-1116. PubMed ID: 34965292
[TBL] [Abstract][Full Text] [Related]
10. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
11. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
[TBL] [Abstract][Full Text] [Related]
12. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Hachitanda Y; Tsuneyoshi M; Enjoji M
Arch Pathol Lab Med; 1989 Apr; 113(4):381-4. PubMed ID: 2495784
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents.
Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R
Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic score.
Klijanienko J; Couturier J; Brisse H; Pierron G; Fréneaux P; Berger F; Maciorowski Z; Sastre-Garau X; Michon J; Schleiermacher G
Cancer Cytopathol; 2011 Dec; 119(6):411-23. PubMed ID: 21774092
[TBL] [Abstract][Full Text] [Related]
15. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
17. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
[TBL] [Abstract][Full Text] [Related]
19. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic large cell neuroblastoma.
Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]